ISSN: 1859 - 2872
To evaluate the results of concurrent chemoradiation therapy in patients with nasopharyngeal cancer at National Otolaryngology Hospital
Main Article Content
Keywords
Abstract
Objective: To evaluate the results of concurrent chemoradiation therapy in patients with nasopharyngeal cancer at National Otolaryngology Hospital. Subject and method: The retrospective study followed up on 50 patients with nasopharyngeal cancer being treated with concurrent chemoradiotherapy at National Otolaryngology Hospital. Duration of treatment is from 2019 to 2022. Result: Overall complete response rate was 92%; complete response in tumor was 96%; complete lymph node response was 95%. Acute and chronic complications were mainly grade 2. Conclusion: The overall response rate to chemotherapy and radiotherapy for nasopharyngeal cancer is high; However, the follow-up time is not long, so the rate of recurrence and metastasis after treatment has not been evaluated.
Article Details
References
2. Chua ML, WJ, Hui EP, Chan AT (2016) Nasopharyngeal carcinoma. Lancet.
3. Chen L, Mao YP, Xie FY, Liu LZ, Sun Y, Tian L, Tang LL, Lin AH, Li L, Ma J (2012) The seventh edition of UICC/AJCC staging system for nasopharyngeal carcinoma is prognostically useful for patients treated with intensity-modulated radiotherapy from an endemic area in China. Radiother. Oncol 104: 331-337.
4. Bing-Jian Feng (2013) Descriptive, environmental and genetic epidemiology of nasopharyngeal carcinoma. Nasopharyngeal Carcinoma: Keys for Translational Medicine and Biology. Landes Bioscience and Springer Science+Business Media, NewYork 778: 23-41.
5. Wei KR, Yu YL, Yang YY, Ji MF, Yu BH, Liang ZH, Reng X (2010) Epidemiological trends of nasopharyngeal carcinoma in China. Asian Pac J Cancer Prev 11(1): 29-32.
6. Quang BV (2012) Nghiên cứu điều trị ung thư vòm mũi họng giai đoạn III, IV (M0) bằng hóa xạ trị gia tốc 3 chiều (3D) theo hình dạng khối u. Luận án tiến sĩ Y học, Trường Đại học Y Hà Nội.
7. Xu T, Hu C, Wang X, Shen C (2011) Role of chemoradiotherapy in intermediate prognosis nasopharyngeal carcinoma. Oral Oncol 47(5): 408- 413.
8. Ngô Thanh Tùng (2015) Ung thư vòm mũi họng. Xạ trị một số bệnh ung thư đầu mặt cổ. Nhà xuất bản Y học, Hà Nội, 95-127.
9. Lê Chính Đại (2007) Nghiên cứu điều trị phối hợp hóa-xạ trị và xạ trị đơn thuần bệnh ung thư vòm mũi họng giai đoạn III, IV (Mo). Luận án Tiến sỹ Y học, Trường Đại học Y Hà Nội.
10. Chen Y, Liu MZ, Liang SB, Zong JF, Mao YP, Tang LL, Guo Y, Lin AH, Zeng XF, Ma J (2008) Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china. Int J Radiat Oncol Biol Phys 71(5): 1356-1364.
Article Sidebar
